ST-067
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ST-067, covering 2024-11-15 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma [Phase 1, Phase 2]